Venoarterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock: The impact of cannulation strategy on survival.


Journal

Perfusion
ISSN: 1477-111X
Titre abrégé: Perfusion
Pays: England
ID NLM: 8700166

Informations de publication

Date de publication:
10 2023
Historique:
medline: 23 10 2023
pubmed: 17 7 2022
entrez: 16 7 2022
Statut: ppublish

Résumé

The optimal venoarterial extracorporeal membrane oxygenation (VA ECMO) cannulation strategy in patients with postcardiotomy cardiogenic shock is still debatable. Studies evaluating the effect of cannulation strategy on long-term survival are scarce. We investigated the impact of central versus peripheral cannulation strategy for ECMO insertion on hospital outcomes and survival in postcardiotomy cardiogenic shock patients. This retrospective study involved 101 patients who had either central or peripheral ECMO due to postcardiotomy shock between June 2009 and December 2020. Study endpoints were limb ischemia, bleeding, blood transfusion, wound infection, and overall survival. Eighty-four patients received central (c) ECMO, and 17 patients had peripheral (p) ECMO. In the group of pECMO, limb ischemia was significantly higher (5 [29.41%] vs 6 [7.14%]; Peripheral ECMO was associated with an increased risk of limb ischemia; however, bleeding, blood transfusion, infection, and 30-day mortality were comparable to central ECMO. Central cannulation was associated with a better 1-year survival rate. Therefore, central cannulation might be the preferred strategy for patients with postcardiotomy cardiogenic shock.

Sections du résumé

BACKGROUND
The optimal venoarterial extracorporeal membrane oxygenation (VA ECMO) cannulation strategy in patients with postcardiotomy cardiogenic shock is still debatable. Studies evaluating the effect of cannulation strategy on long-term survival are scarce.
OBJECTIVES
We investigated the impact of central versus peripheral cannulation strategy for ECMO insertion on hospital outcomes and survival in postcardiotomy cardiogenic shock patients.
METHODS
This retrospective study involved 101 patients who had either central or peripheral ECMO due to postcardiotomy shock between June 2009 and December 2020. Study endpoints were limb ischemia, bleeding, blood transfusion, wound infection, and overall survival.
RESULTS
Eighty-four patients received central (c) ECMO, and 17 patients had peripheral (p) ECMO. In the group of pECMO, limb ischemia was significantly higher (5 [29.41%] vs 6 [7.14%];
CONCLUSIONS
Peripheral ECMO was associated with an increased risk of limb ischemia; however, bleeding, blood transfusion, infection, and 30-day mortality were comparable to central ECMO. Central cannulation was associated with a better 1-year survival rate. Therefore, central cannulation might be the preferred strategy for patients with postcardiotomy cardiogenic shock.

Identifiants

pubmed: 35841146
doi: 10.1177/02676591221114954
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1444-1452

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Fatimah A Alhijab (FA)

Department of Adult Cardiac Surgery , Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.

Tarek M Tantawy (TM)

Department of Intensive Care, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.
Department of Intensive Care, Cairo University, Cairo, Egypt.

Huda H Ismail (HH)

Department of Adult Cardiac Surgery , Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.

Mohammed AlBarrak (M)

Department of Intensive Care, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.

Adam I Adam (AI)

Department of Adult Cardiac Surgery , Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.

Makhlouf Belghith (M)

Department of Intensive Care, Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.

Essam Hassan (E)

Department of Adult Cardiac Surgery , Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.
Department of Cardiothoracic Surgery, Tanta University, Tanta, Egypt.

Claudio Pragliola (C)

Department of Adult Cardiac Surgery , Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.

Monirah A Albabtain (MA)

Department of Cardiology Clinical Pharmacy, Prince Sultan Cardiac Centre, Riyadh, Saudi Arabia.

Amr A Arafat (AA)

Department of Adult Cardiac Surgery , Prince Sultan Cardiac Center, Riyadh, Saudi Arabia.
Department of Cardiothoracic Surgery, Tanta University, Tanta, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH